EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Use of complementary therapies and supportive measures of patients with intracranial gliomas—a prospective evaluation in an outpatient clinic

Malte Ottenhausen, Mirjam Renovanz, Isabell Bartz, Alicia Poplawski, Darius Kalasauskas, Harald Krenzlin, Naureen Keric, Florian Ringel

Journal of Neuro-Oncology · 2024

DOI: 10.1007/s11060-024-04696-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, 2024. Verfasst von Malte Ottenhausen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University Medical Center Mainz, Mainz, Germany. malte.ottenhausen@unimedizin-mainz.de. Hauptthemen laut MEDLINE: Complementary Therapies, Glioma, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsmedizin der Johannes Gutenberg-Universität Mainz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Patients with intracranial gliomas frequently seek for complementary and alternative medicine (CAM), in addition to guideline-directed therapy. In this study, we therefore assessed patients’ information needs regarding treatment and support, and evaluated their attitudes toward experimental trials and alternative therapies.

Methods

A prospective, cross-sectional, descriptive survey was conducted in our center. We developed an interview focusing on how patients obtain further information about therapy and the use of alternative/complementary therapies.

Results

A total of 102 patients participated in the survey. 50% ( n = 51) of patients reported that they had not attempted any additional therapies. When patients attempted self-therapy, it was most commonly in the areas of nutrition (25%, n = 26) and dietary supplements (17%, n = 17). Alternative or complementary therapies were used by 14% ( n = 14) of the patients. Younger age (Odds ratio (OR) 0.96 (95% Confidence interval (CI) 0.92–0.99, p = 0.012) and tumor entity (OR 5.01 (95% CI 1.66–15.11, p = 0.004) for grade 4 vs. 3 tumors and OR 7.22 (95% CI 1.99–26.28) for grade 4 vs. other tumors p = 0.003) were significantly associated with a greater interest in CAM.

Conclusions

Interest in complementary and alternative medicine, as well as nutrition and dietary supplements is high (51%) among glioma patients, and significantly higher among younger patients and those with a worse diagnosis (WHO grade 4). A comprehensive approach to information, including paramedical topics, is needed to provide optimal patient counseling and care for glioma patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Complementary TherapiesGliomaBrain NeoplasmsHumansFemaleMaleMiddle AgedProspective StudiesCross-Sectional StudiesAdultAgedAmbulatory Care FacilitiesYoung AdultSurveys and Questionnaires

Stichwörter der Autor:innen

CAMComplementary therapiesGliomaSupportive care

Autor:innen und Institutionen

  • Department of Neurosurgery, University Medical Center Mainz, Mainz, Germany. malte.ottenhausen@unimedizin-mainz.de.
  • Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard-Karls-University of Tübingen, Tübingen, Germany.
  • Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany.
  • Department of Neurosurgery, University Hospital Tübingen, Tübingen, Germany.
  • Department of Neurosurgery, University Medical Center Mainz, Mainz, Germany.
  • Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, 55131, Mainz, Germany.

Förderung

  • Universitätsmedizin der Johannes Gutenberg-Universität Mainz

Zitieren

APA

Ottenhausen, M., Renovanz, M., Bartz, I., Poplawski, A., Kalasauskas, D., Krenzlin, H., Keric, N., & Ringel, F. (2024). Use of complementary therapies and supportive measures of patients with intracranial gliomas—a prospective evaluation in an outpatient clinic. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04696-1

Vancouver

Ottenhausen M, Renovanz M, Bartz I, Poplawski A, Kalasauskas D, Krenzlin H, et al. Use of complementary therapies and supportive measures of patients with intracranial gliomas—a prospective evaluation in an outpatient clinic. Journal of Neuro-Oncology. 2024. doi:10.1007/s11060-024-04696-1

BibTeX
@article{Ottenhausen2024,
  author = {Ottenhausen, Malte and Renovanz, Mirjam and Bartz, Isabell and Poplawski, Alicia and Kalasauskas, Darius and Krenzlin, Harald and Keric, Naureen and Ringel, Florian},
  title = {Use of complementary therapies and supportive measures of patients with intracranial gliomas—a prospective evaluation in an outpatient clinic},
  journal = {Journal of Neuro-Oncology},
  year = {2024},
  doi = {10.1007/s11060-024-04696-1}
}
Kostenlos starten →